Does Bifidobacterium infantis Help With Preterm Lung Outcomes?
May reduce the risk and severity of bronchopulmonary dysplasia in very preterm infants when combined with Clostridium butyricum.
Weak EvidenceEvidence Summary
May reduce the risk and severity of bronchopulmonary dysplasia in very preterm infants when combined with Clostridium butyricum.
Effective Dose
No established dose from provided studies
Supporting Studies
Every PMID below is a real paper indexed in PubMed. Click any to read the abstract or full text. These are the specific studies HypeCheck cited to support this claim — verify the chain yourself.
Products Containing Bifidobacterium infantis
No products analyzed yet that contain this ingredient.